Belgian (BEL20) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Aug 23, 2025

Explore the Belgian (BEL20) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

Company	Last Price	1D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ARGX argenx	€565.60	-1.8%	21.7%	€34.6b	€690.47	PE31.7x	E25.3%	n/a
UCB UCB	€197.30	-0.9%	22.6%	€37.5b	€220.50	PE28.1x	E17.6%	0.7%
TUB Financière de Tubize	€160.60	-0.4%	36.8%	€7.1b	€186.25	PE77.1x	n/a	0.6%
OXUR Oxurion	€0.025	1.6%	-97.5%	€1.3m	n/a	PE10.6x	n/a	n/a
CYAD Celyad Oncology	€0.40	0.3%	66.3%	€17.9m	n/a	PS96x	n/a	n/a
BIOS BioSenic	€0.0026	4.0%	-70.8%	€1.7m	n/a	PE-0.2x	n/a	n/a
ALEMS European Medical Solutions	€4.70	6.8%	-33.2%	€19.9m	n/a	PE36.4x	n/a	n/a
HYL Hyloris Pharmaceuticals	€6.70	5.7%	1.5%	€187.6m	€13.00	PS19.2x	E60.0%	n/a